Structured Summary
Abstract
An application that must be submitted to a regulatory agency (the FDA in the United States) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (From the New Medicines in Development Series produced by the Pharmaceutical Manufacturers Association and published irregularly.)
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
1 entry terms
- Investigational New Drug Applications
MeSH Record
Aspects Covered
5 allowable subheadings
Indexed with the subheadings economics, history, legislation & jurisprudence, methods, organization & administration.
MeSH Record
Indexing Annotation
U.S. or foreign, but if U.S., new drug "must be submitted to the FDA" before study in humans
MeSH Record
History Note
93
MeSH Record
Previous Indexing
- Drugs, Investigational (1990-1992)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Investigational New Drug Application. Medical Subject Headings (MeSH). 2026. Unique ID D017387. http://id.nlm.nih.gov/mesh/2026/D017387
- Investigational New Drug Application. In: Wikidata. https://www.wikidata.org/wiki/Q72370160